NGEN·64082X203·US·equity·Healthcare - Biotechnology
NGEN (NERVGEN PHARMA CORP) is held by 27 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($756,473), MARSHALL WACE, LLP ($755,355), ROYAL BANK OF CANADA ($648,000). Net institutional sentiment: Bullish.
See how NGEN's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Showing 1-20 of 27
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer